-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

653A.O1.6 653. Myeloma and Plasma Cell Dyscrasias: Clinical-Prospective Therapeutic Trials: Immune Therapy for Multiple Myeloma

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Biological, Clinical Research, Plasma Cell Disorders, Diseases, Therapies, Immunotherapy, Lymphoid Malignancies
Monday, December 13, 2021: 6:15 PM-7:45 PM
A411-A412, Level 4, Building A (Georgia World Congress Center)
Moderators:
Sonja Zweegman, Amsterdam UMC, Vrije Universiteit Amsterdam and Graham Jackson, MBBS, FRCP, FRCPath, MA, DM, NCCC Freeman Road Hospital
Disclosures:
Zweegman: Janssen: Membership on an entity's Board of Directors or advisory committees, Research Funding; Takeda: Membership on an entity's Board of Directors or advisory committees, Research Funding; BMS: Membership on an entity's Board of Directors or advisory committees; Sanofi: Membership on an entity's Board of Directors or advisory committees; Oncopeptides: Membership on an entity's Board of Directors or advisory committees.
6:15 PM

Michael Sebag, MD, PhD1, Noopur S. Raje, MD2, Nizar J. Bahlis, MD3, Caitlin Costello, MD4, Bhagirathbhai Dholaria, MBBS5, Melhem Solh, MD6, Moshe Y. Levy, MD7,8, Michael H. Tomasson, MD9, Harman Dube, PhD10*, Michael A. Damore, PhD10*, Hoi Ken Lon, PhD10*, Cynthia Basu, PhD11*, Athanasia Skoura, PhD12*, Edward Chan, MD13*, Suzanne Trudel, MD14, Andrzej Jakubowiak15, Michael P. Chu, MD16, Cristina Gasparetto, MD17, Andrew P. Dalovisio, MD18 and Alexander Lesokhin, MD19

1Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
2Massachusetts General Hospital Cancer Center, Boston, MA
3Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada
4UC San Diego Health, Moores Cancer Center, La Jolla, CA
5Vanderbilt University Medical Center, Nashville, TN
6BMT Group of Georgia, BMT Group of Georgia, Atlanta, GA
7Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX
8Baylor Scott & White Research Institute, Dallas, TX
9University of Iowa, Iowa City, IA
10Pfizer, San Diego, CA
11Early Clinical Development, Pfizer, San Diego, CA
12Oncology Research and Development, Pfizer, Collegeville, PA
13Oncology Research and Development, Pfizer, San Francisco, CA
14Princess Margaret Cancer Centre, Toronto, ON, Canada
15University of Chicago, Chicago, IL
16Cross Cancer Institute, Edmonton, AB, Canada
17Duke University Hospital, Durham, NC
18Department of Hematology and Oncology, Ochsner Health, Jefferson, LA
19Memorial Sloan Kettering Cancer Center, New York, NY

6:30 PM

Philippe Moreau, MD, PhD1*, Saad Z. Usmani, MD MBA FACP2, Alfred L. Garfall3*, Niels W.C.J. van de Donk4, Hareth Nahi5*, Jesus San-Miguel6, Albert Oriol7*, Ajay K. Nooka8, Thomas Martin, MD9, Laura Rosinol10*, Ajai Chari, MD11*, Lionel Karlin12*, Lotfi Benboubker13*, Maria-Victoria Mateos14, Nizar J. Bahlis, MD15, Rakesh Popat, MBBS, FRCPath, PhD16*, Britta Besemer17*, Joaquín Martínez-López18*, Surbhi Sidana, MD19, Lixia Pei20*, Danielle Trancucci20*, Raluca I. Verona21*, Suzette Girgis21, Yunsi Olyslager22*, Mindy Jaffe21*, Clarissa M. Uhlar21*, Tara Stephenson21*, Rian Van Rampelbergh22*, Arnob Banerjee21*, Jenna D. Goldberg20*, Rachel Kobos20 and Amrita Y. Krishnan, MD23

1Hematology Clinic, University Hospital Hôtel-Dieu, Nantes, France
2Levine Cancer Institute/Atrium Health, Charlotte, NC
3Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
4Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
5Karolinska University Hospital at Huddinge, Karolinska Institute, Stockholm, Sweden
6Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain
7Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
8Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
9University of California San Francisco, San Francisco, CA
10Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain
11Mount Sinai School of Medicine, New York, NY
12Service d’Hématologie Clinique, Centre Hospitalier Lyon Sud, Pierre-Bénite, France
13Service d'Hématologie et Thérapie Cellulaire, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire (CHRU), Tours, France
14University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
15Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
16University College London Hospitals, NHS Foundation Trust, London, United Kingdom
17Department of Hematology, Oncology, and Immunology, University of Tuebingen, Tuebingen, Germany
18Haematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, CNIO, CIBERONC, Madrid, Spain
19Stanford University School of Medicine, Stanford, CA
20Janssen Research & Development, Raritan, NJ
21Janssen Research & Development, Spring House, PA
22Janssen Research & Development, Antwerp, Belgium
23City of Hope Comprehensive Cancer Center, Duarte, CA

6:45 PM

Natalie S. Callander, MD1, Vincent Ribrag, MD2, Paul G. Richardson, MD3, Ajay K. Nooka4, Kevin Song, MD, FRCPC5, Katarina Uttervall, MD, PhD6*, Monique C. Minnema, MD7, Katja Weisel8*, Hang Quach, FRACP, FRCPA9, Chang-Ki Min, M.D., Ph.D.10*, Marc S. Ballas, MD, MPH11*, Xiaofang Li11*, Nirav Ratia12*, Morrys Kaisermann, MD, PhD11*, Beata Holkova, MD11* and Suzanne Trudel, MD13

1Carbone Cancer Center, University of Wisconsin, Madison, WI
2Institut Gustave Roussy, Villejuif, France
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Emory University, Winship Cancer Institute, Atlanta, GA
5Vancouver General Hospital, Vancouver, BC, Canada
6Karolinska University Hospital, Stockholm, Sweden
7University Medical Center Utrecht, Utrecht, Netherlands
8University Medical Center Hamburg-Eppendorf, Hamburg, Germany
9University of Melbourne, St. Vincent’s Hospital Melbourne, Melbourne, VIC, Australia
10Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
11GlaxoSmithKline, Upper Providence, PA
12GlaxoSmithKline, Brentford, Middlesex, United Kingdom
13Princess Margaret Cancer Centre, Toronto, ON, Canada

7:00 PM

Dan T. Vogl1*, Jonathan L. Kaufman, MD2, Sarah A. Holstein, MD, PhD3, Shebli Atrash, MD4, Omar Nadeem, MD5, Murali Janakiram, MD, MS6*, Kaveri Suryanarayan, MD7*, Yuyin Liu7*, Sabrina Collins7*, Xavier Parot, MD7* and Maria Chaudhry, MBBS8

1Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
2Winship Cancer Institute of Emory University, Atlanta, GA
3Nebraska Medical Center, Omaha, NE
4Levine Cancer Institute, Charlotte, NC
5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
6University of Minnesota, Minneapolis, MN
7Takeda Development Center Americas, Inc. (TDCA), Lexington, MA
8Ohio State University Comprehensive Cancer Center, Columbus, OH

7:15 PM

David J. Chung, MD, PhD1, Nina Shah, MD2, Dina Stroopinsky3*, Juan WU4*, Lina Bisharat5*, Natalie S. Callander, MD6, Brent R. Logan, PhD7*, Kenneth C. Anderson, MD8,9,10, Thinle Chodon, MD11*, Meera Mohan, MD12,13, Steven Devine, MD14, Yvonne A. Efebera, MD, MPH15, Nancy Geller, PhD16*, Peiman Hematti, MD17, Leona A. Holmberg, MD, PhD18, Alan Howard, PhD19*, Bryon Johnson, PhD20, Hillard M Lazarus, MD21, Ehsan Malek, MD22, Philip L. McCarthy, MD23, David H. McKenna, MD24, Adam M. Mendizabal, MS25, Nikhil C. Munshi, MD, PhD26, Lynn O'Donnell, PhD27*, Aaron P. Rapoport, MD28, Ajay K. Nooka29, Jane Reese30*, Robert J. Soiffer, MD31, Lynne Uhl, MD32, Giulia Cheloni, PhD3*, Dimitra Karagkouni, PhD3*, Ioannis Vlachos, PhD3*, James W. Young, MD33, Jacalyn Rosenblatt, MD5, Edmund K. Waller, PhD, MD29, Marcelo C Pasquini, MD, MS34,35 and David Avigan, MD5,36

1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2University of California San Francisco, San Francisco, CA
3Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
4The Emmes Corporation, Rockville, MD
5Beth Israel Deaconess Medical Center, Boston, MA
6University of Wisconsin, Madison, WI
7Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
8Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA
9Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA
10The LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Boston, MA
11Roswell Park, Buffalo, NY
12Medical College of Wisconsin, Milwaukee, WI
13Clinical Cancer Center, Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI
14National Marrow Donor Program, Minneapolis, MN
15Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
16National Institutes of Health, Bethesda, MD
17Division of Hematology/Oncology, University of Wisconsin School of Medicine & Public Health, Madison, WI
18Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
19Center for International Blood and Marrow Transplant Research, Manager, Immunobiology Research, Minneapolis, MN
20Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
21Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Cleveland Medical Center, Shaker Heights, OH
22Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH
23Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
24Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN
25The Emmes Company, Rockville, MD
26Dana-Farber Cancer Institute, Harvard Medical School, Boston
27Comprehensive Cancer Center, Ohio State University Medical Center - James Cancer Hospital, Columbus, OH
28Division of Hematology and Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
29Winship Cancer Institute, Emory University, Atlanta, GA
30Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
31Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
32Department of Pathology, Beth Israel Deaconess Med. Ctr., Boston, MA
33Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
34CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine,, Froedtert & The Medical College Cancer Ctr., Milwaukee, WI
35Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
36Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA

7:30 PM

Shaji K Kumar, MD1, Anita D'Souza, MD, MS2,3,4, Nina Shah, MD5,6, Cesar Rodriguez7, Peter M. Voorhees, MD8, Orlando F. Bueno, MD, PhD9, Ben Buelow, MD10, Kevin J. Freise, PhD, MS9, Susan Yue, MD9*, Rajvineeth Kumar Pothacamury, MD11*, Akshanth R. Polepally, PhD11* and Ravi Vij, MBBS12

1Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
2Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
3Division of Hematology Oncology, CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
4CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
5University of California San Francisco, San Francisco, CA
6Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA
7Medical Oncology and Hematology, Wake Forest University School of Medicine, Winston-Salem, NC
8Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Center, Charlotte, NC
9AbbVie, Inc., North Chicago, IL
10TeneoBio, Inc., Menlo Park, CA
11AbbVie Inc., North Chicago, IL
12Washington University School of Medicine, Ballwin, MO

*signifies non-member of ASH